In this podcast, we feature an article about a recent DCAT Benchmarking study, conducted prior to COVID-19, that provides insights on whether biopharma companies and their suppliers believe the deteriorating trade environment is a major threat, and what they are doing to confront the real and potential risks to their supply chains. For a text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Examining trade-related risks
- Study’s background
- Sources of supply-chain risk
- Awareness of supply-chain risk
- Managing supply-chain risks
- US market scenarios
- Vulnerable industry supply chains
